Product NDC: | 0591-2790 |
Proprietary Name: | tizanidine hydrochloride |
Non Proprietary Name: | tizanidine hydrochloride |
Active Ingredient(s): | 6 mg/1 & nbsp; tizanidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-2790 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021447 |
Marketing Category: | NDA |
Start Marketing Date: | 20120206 |
Package NDC: | 0591-2790-86 |
Package Description: | 150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2790-86) |
NDC Code | 0591-2790-86 |
Proprietary Name | tizanidine hydrochloride |
Package Description | 150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2790-86) |
Product NDC | 0591-2790 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tizanidine hydrochloride |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20120206 |
Marketing Category Name | NDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | TIZANIDINE HYDROCHLORIDE |
Strength Number | 6 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |